Why the study?
Are sarcopenia and reduced ASM associated with higher levels of BNP and NT-proBNP in patients with heart failure?
Are sarcopenia and reduced ASM associated with higher levels of BNP and NT-proBNP in patients with heart failure?
Answers are grounded in this paper and cite their sources.
Sarcopenia and reduced appendicular skeletal muscle mass are associated with elevated BNP and NT-proBNP levels in heart failure patients.
In patients with HF, sarcopenia and reduced ASM are associated with considerably higher plasma levels of BNP and NT-proBNP. Future research is required to investigate whether sarcopenia may express dysregulated biomarkers of cardiac function.
No takes yet. Share an insight, caveat, or question.
Prokopidis et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: